Fractyl Health, Inc. (GUTS) vs InterCure Ltd. (INCR)
A side-by-side comparison of Fractyl Health, Inc. and InterCure Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GUTS
Fractyl Health, Inc.
$4.46HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
INCR
InterCure Ltd.
$5.30HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
Total return — GUTS vs INCR
growth of $100 · dividends reinvested · last 3yGUTS -97.0% (-69.1%/yr)INCR -9.2% (-3.2%/yr)INCR compounded faster over this window
Log scale — wide-divergence pair
GUTS INCR
GUTS vs INCR: by the numbers
- •INCR is the larger company ($63M vs $59M market cap).
- •Both run net losses; GUTS's is the smaller (0.00% vs -13.72% net margin).
Metrics side by side
Valuation
| Metric | GUTS | INCR |
|---|---|---|
| P/S ratio | N/A | 0.79 |
| P/B ratio | N/A | 0.50 |
| FCF yield | N/A | 11.71% |
Profitability
| Metric | GUTS | INCR |
|---|---|---|
| Gross margin | 0.00% | 14.40% |
| Operating margin | 0.00% | 2.49% |
| Net margin | 0.00% | -13.72% |
| ROE | N/A | -8.80% |
| ROIC | -129.67% | -4.72% |
Growth (annualized)
| Metric | GUTS | INCR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 32.71% |
| Total return CAGR (5Y) | N/A | -30.85% |
Go deeper
Dig into the metrics
Fractyl Health ROEInterCure ROEFractyl Health operating marginInterCure operating marginFractyl Health revenue growthInterCure revenue growthFractyl Health free cash flowInterCure free cash flow
Fractyl Health & InterCure appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.